Kieron Dunleavy1, Wyndham H Wilson. Show Affiliations » 1. Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
Abstract
Entities: Disease Gene
Mesh： See more » AlemtuzumabAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAntibodies, Neoplasm/therapeutic useAntigens, CD/immunologyAntigens, Neoplasm/immunologyAntineoplastic Agents/therapeutic useCD52 AntigenGlycoproteins/antagonists & inhibitorsGlycoproteins/immunologyHumansImmunoblastic Lymphadenopathy/drug therapyImmunoblastic Lymphadenopathy/immunologyImmunoblastic Lymphadenopathy/pathologyLymphoma, T-Cell/drug therapyLymphoma, T-Cell/immunologyLymphoma, T-Cell/pathology
Substances： See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntibodies, NeoplasmAntigens, CDAntigens, NeoplasmAntineoplastic AgentsCD52 AntigenCD52 protein, humanGlycoproteinsAlemtuzumab
Year: 2010 PMID： 20795788 DOI： 10.3109/10428194.2010.508190
Source DB: PubMed Journal: Leuk Lymphoma ISSN： 1026-8022